These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25638392)

  • 1. Mitochondrial Diseases Part III: Therapeutic interventions in mouse models of OXPHOS deficiencies.
    Peralta S; Torraco A; Iommarini L; Diaz F
    Mitochondrion; 2015 Jul; 23():71-80. PubMed ID: 25638392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial Diseases Part I: mouse models of OXPHOS deficiencies caused by defects in respiratory complex subunits or assembly factors.
    Torraco A; Peralta S; Iommarini L; Diaz F
    Mitochondrion; 2015 Mar; 21():76-91. PubMed ID: 25660179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial Diseases Part II: Mouse models of OXPHOS deficiencies caused by defects in regulatory factors and other components required for mitochondrial function.
    Iommarini L; Peralta S; Torraco A; Diaz F
    Mitochondrion; 2015 May; 22():96-118. PubMed ID: 25640959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches and limitations to gene therapy for mitochondrial diseases.
    Owen R; Flotte TR
    Antioxid Redox Signal; 2001 Jun; 3(3):451-60. PubMed ID: 11491656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders.
    Tischner C; Wenz T
    Mitochondrion; 2015 Sep; 24():32-49. PubMed ID: 26134435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGC-1alpha activation as a therapeutic approach in mitochondrial disease.
    Wenz T
    IUBMB Life; 2009 Nov; 61(11):1051-62. PubMed ID: 19859975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial diseases: Drosophila melanogaster as a model to evaluate potential therapeutics.
    Foriel S; Willems P; Smeitink J; Schenck A; Beyrath J
    Int J Biochem Cell Biol; 2015 Jun; 63():60-5. PubMed ID: 25666557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse models of oxidative phosphorylation defects: powerful tools to study the pathobiology of mitochondrial diseases.
    Torraco A; Diaz F; Vempati UD; Moraes CT
    Biochim Biophys Acta; 2009 Jan; 1793(1):171-80. PubMed ID: 18601959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging therapeutic approaches to mitochondrial diseases.
    Wenz T; Williams SL; Bacman SR; Moraes CT
    Dev Disabil Res Rev; 2010; 16(2):219-29. PubMed ID: 20818736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The transmission of OXPHOS disease and methods to prevent this.
    Jacobs LJ; de Wert G; Geraedts JP; de Coo IF; Smeets HJ
    Hum Reprod Update; 2006; 12(2):119-36. PubMed ID: 16199488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapy for mitochondrial disorders: little proof, high research activity, some promise.
    Suomalainen A
    Semin Fetal Neonatal Med; 2011 Aug; 16(4):236-40. PubMed ID: 21676668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mitochondrial DNA diseases and therapeutic strategies].
    Tonin Y; Entelis N
    Med Sci (Paris); 2014 Dec; 30(12):1101-9. PubMed ID: 25537040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for treating disorders of the mitochondrial genome.
    Smith PM; Ross GF; Taylor RW; Turnbull DM; Lightowlers RN
    Biochim Biophys Acta; 2004 Dec; 1659(2-3):232-9. PubMed ID: 15576056
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of individual patient's fibroblasts in the search for personalized treatment of nuclear encoded OXPHOS diseases.
    Saada A
    Mol Genet Metab; 2011; 104(1-2):39-47. PubMed ID: 21835663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast as a system for modeling mitochondrial disease mechanisms and discovering therapies.
    Lasserre JP; Dautant A; Aiyar RS; Kucharczyk R; Glatigny A; Tribouillard-Tanvier D; Rytka J; Blondel M; Skoczen N; Reynier P; Pitayu L; Rötig A; Delahodde A; Steinmetz LM; Dujardin G; Procaccio V; di Rago JP
    Dis Model Mech; 2015 Jun; 8(6):509-26. PubMed ID: 26035862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of mitochondrial diseases.
    Ylikallio E; Suomalainen A
    Ann Med; 2012 Feb; 44(1):41-59. PubMed ID: 21806499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling biochemical features of mitochondrial neuropathology.
    Bird MJ; Thorburn DR; Frazier AE
    Biochim Biophys Acta; 2014 Apr; 1840(4):1380-92. PubMed ID: 24161927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular genetic and clinical aspects of mitochondrial disorders in childhood.
    Moslemi AR; Darin N
    Mitochondrion; 2007 Jul; 7(4):241-52. PubMed ID: 17376748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for fighting mitochondrial diseases.
    Viscomi C; Zeviani M
    J Intern Med; 2020 Jun; 287(6):665-684. PubMed ID: 32100338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement.
    Wallace DC
    Gene; 2005 Jul; 354():169-80. PubMed ID: 16024186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.